Diss. (sammanfattning) Umeå : Univ., 2003. / Härtill 4 uppsatser.

Thesis (M.Sc. (Microbiology))--Mahidol University, 1999.

Cerebral malaria is a common encephalopathy in African children, but the cause of death and neurological sequelae are unknown. This dissertation examines the hypothesis that raised intracranial pressure (ICP) is a determinant of poor outcome in Kenyan children with cerebral malaria. The opening cerebrospinal fluid pressure was raised in all 26 children in whom it was measured on admission and 92% of 35 children in whom it was measured after admission. Brain stem signs, particularly an abnormal respiratory pattern, absent pupillary responses and a lack of spontaneous eye movement were associated with a death. In 33 children who died with cerebral malaria, at least 18-42% had clinical features of transtentorial herniation, according to the criteria used. Intracranial pressure monitoring was performed in 18 children with severe CM, of whom 14 had computerised tomography (CT) and in 10 the basal cranial arteries were monitored with transcranial Doppler (TCD) sonography. Three children with severe intracranial hypertension (maximum ICP > 60 mmHg and minimum cerebral perfusion pressure (CPP) < 40 mmHg) had a poor outcome despite aggressive therapy with mannitol. One child with a maximum ICP of 151 mmHg died with the signs of uncal and medullary stages of herniation. In the other 2 children, middle cerebral artery velocity and vascular resistance monitored with TCD sonography changed with ICP and CPP. Both of these children had diffuse brain swelling associated with generalised hypodensity on their acute CT scans. These children survived° with cerebral atrophy on their convalescent scans and severe neurological deficits. In the 8 children with intermediate intracranial hypertension (maximum ICP 20-60 mmHg and CPP < 50 mmHg) mannitol was effective in controlling the intracranial hypertension. TCD was not reliable in detecting changes in ICP or CPP. Two of these children had acute brain swelling, but the tomographic density was normal and the swelling had resolved when the repeat scans were performed 12-24 days later. All the children with intermediate intracranial hypertension survived without major neurological sequelae. In the remaining 7 children who had ICP monitoring, the maximum ICP was <20 mmHg and mannitol was not administered. None of the CT scans showed brain swelling and the children survived without severe sequelae. In a further 9 children with severe malaria (6 with CM) the agonal stages were monitored with TCD. Three children with CM had sonographic features of progressive intracranial hypertension associated with signs of herniation, whilst the other children (including 3 with CM) did not have these sonographic features, although one had evidence of brainstem compromise before dying. Thus raised ICP is a feature of CM in Kenyan children. Severe intracranial hypertension is associated with a poor outcome and could be responsible for at least a third of the children dying from CM. Mannitol reduces the ICP, but does not prevent nor control severe intracranial hypertension.

Malaria affects 200 million people annually, resulting in 584,000 - 1,238,000 deaths. The majority of these deaths occur in children, less than 5 years of age, in sub-Saharan Africa and are due to cerebral malaria (CM), a neuropathology induced primarily by the species Plasmodium (P.) falciparum. The pathogenesis of CM remains poorly understood and the mechanisms involved in acquired protection against the syndrome in malaria-endemic regions are undefined. Utilising the well characterised P. berghei ANKA experimental infection model of cerebral malaria (ECM), results presented in this thesis show that the development of ECM is associated with the accumulation and arrest of pathogenic CD8+ T cells within the perivascular spaces of the brain. Accumulation of activated CD8+ T cells, without arrest, was observed in the perivascular spaces of the brains of mice infected with the non-ECM causing P. berghei NK65 strain. These data show that the behaviour of intracerebral CD8+ T cells specifies their pathogenic function during malaria infection. The development of ECM was associated with extensive disruption to the BBB, which developed in the absence of extensive CD8+ T cell-dependent endothelial cell apoptosis. We modified the ECM model, establishing an infection-drug cure strategy, to investigate the immunological basis of parasite exposure-induced resistance to ECM development. Three rounds of infection-drug cure promoted resistance to ECM, which was associated with reduced intracerebral expression of genes involved in defence response, regulation of apoptosis, chemotaxis, CTL activity, antigen processing and presentation and cell adhesion, compared with ECM susceptible mice. Additionally, CD8+ T cell activation was suppressed in exposure-induced resistant mice and was associated with the antibody dependent expansion of a splenic plasmacytoid DC population, with a regulatory phenotype. The infection-induced protection against ECM was critically dependent upon secreted antibody production. A long standing problem in studying the immune response to malaria infection has been the inability to track parasite-specific CD4+ T cell responses. To address this, we generated and validated new transgenic P. berghei parasites expressing the model antigen, ovalbumin (OVA), either in the parasite cytoplasm or on the parasitophorous vacuole membrane (PVM). We found that cellular location and expression level of the antigen influence the induction and magnitude of parasite-specific T-cell responses. These parasites thus provide knowledge on the factors that influence the recognition of parasite antigens by the immune system and represent useful tools to study the development and function of antigen-specific T-cell responses during malaria infection. The results in this thesis improve our understanding of the events that lead to the development of CM, and the host immune responses that develop following parasite exposure to protect against it. The results should contribute towards the rational development of adjunctive therapies and effective vaccines for human CM.

Diss. (sammanfattning) Linköping : Univ., 2002. / Härtill 5 uppsatser.

Submitted by JACIARA CRISTINA ALMEIDA DO AMARAL (jaciaramaral@ufpa.br) on 2018-06-25T17:31:15Z No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) DISSERTAÇÃO- MARJORIE FINALSEC.pdf: 2385529 bytes, checksum: a737205933ed5944c458d304889604a7 (MD5) / Approved for entry into archive by JACIARA CRISTINA ALMEIDA DO AMARAL (jaciaramaral@ufpa.br) on 2018-06-25T17:31:41Z (GMT) No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) DISSERTAÇÃO- MARJORIE FINALSEC.pdf: 2385529 bytes, checksum: a737205933ed5944c458d304889604a7 (MD5) / Made available in DSpace on 2018-06-25T17:31:41Z (GMT). No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) DISSERTAÇÃO- MARJORIE FINALSEC.pdf: 2385529 bytes, checksum: a737205933ed5944c458d304889604a7 (MD5) Previous issue date: 2018-05-17 / CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / CNPq - Conselho Nacional de Desenvolvimento Científico e Tecnológico / FAPESPA - Fundação Amazônia de Amparo a Estudos e Pesquisas / A malária cerebral (MC) é uma das complicações mais severas atribuídas à infecção pelo protozoário Plasmodium falciparum, ganhando destaque nas taxas de mortalidade infantil em áreas endêmicas. Esta enfermidade apresenta uma patogênese complexa e ainda pouco elucidada, estando associada a alterações cognitivas, comportamentais e motoras. Visando ampliar os conhecimentos a respeito desta patologia e procurando os benefícios atribuídos ao consumo diário de antioxidantes, o principal objetivo deste trabalho é avaliar o possível efeito protetor do fruto da Euterpe oleracea (açaí) durante a evolução do quadro de malária cerebral experimental (MCE) induzida em modelo murino por meio da inoculação da cepa ANKA de Plasmodium berghei (PbA). Para tal, utilizaram-se camungondos da linhagem albino suíço, os quais foram inoculados intraperitonealmente (i.p.) com 10⁶ de eritrócitos parasitados. Os animais (fêmeas e machos entre 4 a 6 semanas) foram divididos em quatro grupos, dentre os quais os grupos Açaí e PbA+Açaí foram mantidos com uma dieta exclusiva com ração enriquecida com açaí, e aos grupos Controle e PbA foram proporcionadas somente ração padrão durante os 22 dias de experimento. Para caracterização do quadro de MCE foram avaliados diversos parâmetros como o surgimento dos sinais clínicos, curva de sobrevivência, parasitemia (%), ganho de massa corpórea e permeabilidade vascular. Para avaliação das alterações comportamentais e locomotoras dos animais foi utilizado o protocolo SHIRPA. Observamos prolongamento de sobrevida dos animais infectados e tratados com dieta enriquecida com açaí, além de diminuição das alterações neurológicas decorrentes da exposição do parênquima cerebral. Este trabalho nos permitiu validar o desenvovimento do quadro de malária cerebral experimental (MCE) em modelo murino e avaliar o efeito neuroprotetor do açaí (Euterpe oleracea) no decorrer da doença. / Cerebral malaria (CM) is one of the most severe complications attributed to protozoal infection by Plasmodium falciparum, gaining prominence in infant mortality rates in endemic areas. It´s a complex pathogenesis and still little elucidated, being associated with cognitive, behavioral and motor changes. Aiming to broaden the knowledge about this pathology and looking for the benefits attributed to the daily consumption of antioxidants, the objective of this work is to evaluate the possible protective effect of Euterpe oleracea fruit (açaí) during evolution of experimental cerebral malaria (ECM) induced in murine model by means of inoculation of Plasmodium berghei (PbA), ANKA stain. For this, we used the Swiss line, which were inoculated intraperitoneally (i.p.) with 10⁶ of parasited erythrocytes. The animals (females and males between 4 and 6 weeks) were divided into four groups, among which Açaí and PbA+Açaí groups were maintained on a ration-exclusive diet enriched with açaí and the Control and PbA groups were given only standard ration during 22 days of experiment. To characterize the ECM framework, several parameters were evaluated such as the appearence of clinical signs, survival curve, parasitemia, body mass gain and vascular permeability. The SHIRPA protocol was used to evaluate the behavioral and locomotor changes in animals. We observed an extension of survival of the infected animals and treated with a diet enriched with acai berry, and decreased the neurological changes arising from the exposure of the cerebral parenchyma. This work allowed us to validate the development of the experimental brain malaria framework in murine model and evaluate the neuroprotective effect of Acai (Euterpe oleracea) in the course of the disease.

Orientador: Fabio Trindade Maranhão Costa / Dissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia / Made available in DSpace on 2018-08-10T03:13:18Z (GMT). No. of bitstreams: 1 Blanco_YaraCarollo_M.pdf: 1932159 bytes, checksum: 7fa3ee714af53f1bf4da1434c08a29f5 (MD5) Previous issue date: 2007 / Resumo: A malária é sem dúvida a doença parasitária mais importante do mundo, infectando 300-500 milhões de pessoas e levando a óbito cerca de 1-2 milhões de indivíduos anualmente. Malária cerebral (MC) é o mais importante tipo de complicação nas infecções maláricas. MC é uma síndrome multifatorial, entretanto sua patogênese ainda não foi totalmente elucidada. Diversos estudos mostram a adesão de eritrócitos infectados (EI) no endotélio microvascular do hospedeiro. No entanto, várias evidências indicam que um desbalanço da resposta imune e da homeostase, acarretando numa elevada expressão de citocinas pró-inflamatórias também desempenham um papel importante na patogênese da MC. O modelo utilizando camundongos C57BL/6 infectados com Plasmodium berghei ANKA (PbA) parece ser o que mais se assemelha a MC humana, já que em ambos casos ocorre um aumento significativo de citocinas próinflamatórias, da destruição neuronal, da hemorragia cerebral e da concentração de lactato. A terapia de oxigenação hiperbárica (HBO) tem sido amplamente utilizada como potencializador de cicatrização e contra microrganismos anaeróbicos. No entanto, nos últimos anos, diversos estudos têm mostrado que o oxigênio pressurizado é capaz de proteger contra a destruição da barreira hemato-encefálica (BHE), inibir a destruição neuronal, reduzir a produção de citocinas pró-inflamatórias e a expressão ICAM-1, receptor leucocitário, e de EI. Neste estudo, avaliamos os efeitos da HBO na prevenção dos sintomas da MC em camundongos infectados com PbA e nos eritrócitos expostos diretamente ao oxigênio hiperbárico. A utilização do oxigênio hiperbárico mostrou-se capaz de reduzir significativamente a taxa de mortalidade associada à malária cerebral experimental, assim como uma redução da queda da temperatura corporal e dos níveis de parasitemia. Além disso, nossos resultados demonstram que a terapia com oxigênio hiperbárico impede a destruição da BHE. Testes In vitro mostraram que a exposição direta de eritrócitos sadios e de eritrócitos infectados (EI), á HBO não é tóxica e nem capaz de alterar a viabilidade e infectividade de EI. Por último, mostramos que o tratamento com HBO realizado após o quarto dia de infecção (quando a parasitemia já é patente), retarda o aparecimento dos sintomas neurológicos da malária cerebral e morte associada / Abstract: Malaria is the world¿s most nefarious infectious disease, affecting 300-500 million people and leads to death of 1-2 million individuals per year. Cerebral malaria (CM) is the most serious complications that might occur during a malarial infection. CM is a multifactorial syndrome; however its pathogenesis is still a matter of debate. Several studies show that in adhesion of infected erythrocytes (IE) to the host microvascular endothelium is involved. Nevertheless, several bodies of evidence indicate that a unbalance in host immune response and homeostasis, leading to the expression at higher levels of proinflammatory cytokines. Infection of C57BL/6 mice with IE of Plasmodium berghei ANKA (PbA) is the largely used model for CM, as a significant augmentation in the expression levels of proinflammatory cytokines and lactate, neuronal damage and cerebral hemorrhage also occurs. Hyperbaric oxygen therapy (HBO) has been widely used against anaerobic microorganism and as an adjunct therapy in surgeries. However, in the last year several studies have shown that HBO is able to prevent brain-blood-barrier (BBB) breakdown, inhibit neural damage and the syntheses of proinflammatory cytokines and the expression of ICAM-1, a the host receptors involved in the adhesion of leukocytes and IE. Herein, we evaluated the HBO effects in preventing CM specific clinical signs in PbA-infected mice and directly against IE of PbA. The data provided by us demonstrated that HBO treatment reduces significantly CM associated mortality and clinical outcomes, such as hypothermia, BBB dysfunction and is able to inhibit parasite burden early on the infection. In vitro analysis showed that directly exposure to HBO, up to six hours, is not harmful to health erythrocytes neither inhibit parasite development and infectivity. Finally, HBO treatment was able to delay significantly the CM neurological signs and death, even thought administrated after parasite establishment / Mestrado / Mestre em Parasitologia

Orientador: Fabio Trindade Maranhão Costa / Tese (doutorado) - Universidade Estadual de Campinas, Instituto de Biologia / Made available in DSpace on 2018-08-20T23:13:46Z (GMT). No. of bitstreams: 1 Blanco_YaraCarollo_D.pdf: 7163711 bytes, checksum: 880b23b56e210670cf37c82408110b1b (MD5) Previous issue date: 2012 / Resumo: A Malária é a principal doença parasitária do mundo, infectando 300-500 milhões de pessoas e levando ao óbito cerca de 1 milhão de indivíduos anualmente. As infecções maláricas geralmente não apresentam complicações, no entanto, infecções por Plasmodium falciparum podem se desenvolver em formas graves da doença, como a malaria cerebral. A malaria cerebral e considerada uma síndrome multifatorial, envolvendo a citoadesão de eritrócitos infectados por P. falciparum (EIPf) através de diferentes receptores como CD36, ICAM-1, VCAM, P-selectina e E-selectina, sendo o ICAM-1 apontado como o principal receptor. Varias evidências sugerem ainda que o desbalanço da resposta imune do hospedeiro, a ativação endotelial e alterações na cascata de coagulação desempenham papel importante na patogênese da MC. Além disso, outros fatores como a presença de heme livre e NOS também tem sido apontados como essenciais para o desenvolvimento da MC... Observação: O resumo, na íntegra, poderá ser visualizado no texto completo da tese digital / Abstract: Malaria still is a major parasitic disease in the world, infecting 300-500 million people and leading to death about 1 million people annually. Usually malaria infections do not lead to complications, however some infections, mainly, by Plasmodium falciparum can evolve into severe forms of disease such as cerebral malaria (CM). CM is considered a multifactorial syndrome involving cytoadhesion of P. falciparum-infected erythrocytes (PfEI) to different host receptors such as CD36, VCAM, P-selectin and E-selectin and ICAM-1 , which is considered the main receptor involved in MC. A large body of evidences suggests that the imbalance of the host immune response, endothelial activation and changes in the coagulation cascade play an important role in the pathogenesis of CM. Moreover, of free heme, and NOS has also been identified as essential for the development of CM...Note: The complete abstract is available with the full electronic document / Doutorado / Parasitologia / Doutor em Parasitologia

Orientador: Ana Maria Aparecida Guaraldo / Dissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia / Made available in DSpace on 2018-08-14T15:15:00Z (GMT). No. of bitstreams: 1 Pinto_HelenCupertinoSilva_M.pdf: 1411655 bytes, checksum: 74209c9aaeedc867a4d0f783be898b27 (MD5) Previous issue date: 2009 / Resumo: A malária cerebral humana é a manifestação mais grave do Plasmodium falciparum que ocorre em 1% das infecções, sendo responsável por mais de dois milhões de mortes anuais entre crianças abaixo de cinco anos. O modelo experimental mais aceito da malária cerebral é o camundongo C57BL/6 infectado pelo Plasmodium berghei ANKA (PbA). A administração da fração mononuclear da medula óssea, contendo principalmente células tronco mesenquimais e hematopoiéticas, constitui uma estratégia promissora no tratamento de danos neurais causados por acidente vascular cerebral. Neste estudo, foi avaliado o efeito de células da medula óssea de camundongos transgênicos C57BL/6 GFP HET transplantadas em C57BL/6JUnib infectados com 106 hemácias parasitadas pelo PbA. Resumidamente, células perfundidas da medula do fêmur e tíbia de C57BL/6 GFP HET foram purificadas por gradiente de Ficoll (Histopaque) a 1000 x g por 15 minutos. Após duas lavagens em meio RPMI, as células foram ressuspensas em NaCl 0,15 M. No segundo dia após a infecção (dai) pelo PbA, foram injetadas 3,0 x 106 a 4,6 x 107 células de medula óssea (CMO) no plexo oftálmico dos camundongos devidamente anestesiados com ketamina/xylasina (protocolo 1078-1 CEEA/Unicamp). Alguns camundongos receberam apenas a injeção de células totais da medula óssea (CTMO), sem a purificação pelo gradiente de Ficoll. Foi avaliada a integridade da barreira hemato-encefálica, mediante a injeção de azul de Evans 1% no plexo oftálmico em camundongos transplantados e não transplantados com células mononucleares da medula óssea (CMoMO) no 2º dai. Após 3 e 4 dias do transplante, não houve proteção da barreira hemato-encefálica. Para constatação da presença das células de medula óssea no cérebro, outro grupo de camundongos infectados pelo PbA recebeu no 2º dai, 4,6 x 107 CMoMO provenientes de camundongos GFP. Após a manifestação de sinais clínicos da MC os camundongos foram sacrificados para remoção do cérebro e preparo de cortes em criostato. Foi possível observar, sob microscópio de fluorescência, a presença de células da medula no bulbo olfatório de camundongos com MC+. Também foram avaliadas a sobrevivência, a parasitemia e a ação coadjuvante do tratamento com cloroquina (0,8 mg/dia/animal). Todos os 38 animais do grupo controle morreram até o 7º dia de infecção pelo PbA (13,16% no 5º dia, 68,42% no 6º dia e 18,42 % no 7º dai). A injeção de células da medula óssea não interferiu na parasitemia dos animais. Apesar dos animais que superaram a fase aguda da malária cerebral morrerem em decorrência de hiperparasitismo e anemia, o tratamento com células da medula óssea (fração mononuclear ou células totais) mostrou-se capaz de ampliar a sobrevivência em 10 a 21 dias, resultados considerados promissores. As células da medula óssea promoveram a melhora clínica do quadro neurológico da malária cerebral. / Abstract: The cerebral malaria (CM) is the most serious complication of Plasmodium falciparum occurring in 1% of infections, and is responsible for more than two million of annual deaths among children under five years old. The experimental model for brain malaria currently used is the C57BL/6 mice infected by Plasmodium berghei ANKA (PbA). Administration of mononuclear population from bone marrow containing mainly mesenchymal stem cells and haematopoietic stem cells, is a promising strategy to treat neural damages caused by stroke. In this study was evaluated the effect of bone marrow mononuclear cells of transgenic mice C57BL/6 GFP HET transplanted into C57BL/6JUnib, infected by 106 parasitized erythrocyte PbA. Briefly, bone marrow mononuclear cells flushed from femur and tibia of C57BL/6 GFP HET were purified through Ficoll (Histopaque) gradient at 1000xg during 15 minutes. After two washes with RPMI medium, the cells were resuspended in NaCl 0,15M. On the second day after infection (DAI) by PbA, were injected into mice orbital plexus 3x10 6 to 4.6x107 cells of after anaesthesia with Ketamine/Xylazine (protocol nº 1078-1 CEEA/UNICAMP). Some mice received only injection of total bone marrow cells without purification on Ficoll gradient. The injection of bone marrow mononuclear cells on the second day of infection by PbA was unable in recovering the brain blood barrier after three or four days. In order to confirm the presence of bone marrow cells in the brain, another group of infected C57BL/6JUnib received on the second day after infection 4.6 x 107 bone marrow mononuclear cells from GFP mice. They were sacrificed between 6th and 8th day after onset of clinical signs of the CM. After removal and preparation of the brain for criostate cuts, was possible to observe, under fluorescence microscope, the presence of GFP bone marrow cells in the olfactory bulb on CM+ mice. It was evaluated survival, parasitemia and action of the adjuvant treatment of chloroquine (0.8 mg/day/animal) as well. All the 38 animals from control group died until 7th DAI. (13.16% at 5th DAI,68.42% at 6th DAI and 18.42% at 7th DAI). The transplantation of bone marrow cells did not affect the parasitemia. The bone marrow cells therapy infected mice by PbA was able to revert the clinical signs of cerebral malaria, increasing the survival up to 21 days. / Mestrado / Parasitologia / Mestre em Parasitologia

A malária mata mais de um milhão de pessoas por ano, sendo uma das doenças infecciosas mais relevantes e um grande problema de saúde pública. Além disso, o surgimento de cepas resistentes aos quimioterápicos utilizados faz necessário o estudo de novos alvos para tratamentos contra esta doença. No nosso laboratório foi demonstrada a biossíntese de isoprenóides, em P. falciparum pela via MEP. Sabe-se que substâncias inibidoras da biossíntese de isoprenóides, dentre essas os terpenos, apresentam atividade antimalárica. Levando em consideração o anterior, nós avaliamos o potencial antimalárico do álcool perilico (POH) em P. falciparum e P. berghei. Nossos resultados demonstraram que o POH teve efeito inibitório contra o crescimento do P. falciparum in vitro, nas cepas 3D7 e K1 com uma IC50 de 4,8 ± 0,5 &mu;M, e 10,41±2,33 &mu;M, respectivamente. Além disso, o POH não teve efeito tóxico na linhagem celular Vero. Ainda, Comprovamos que o POH inibiu a farnesilação de proteinas entre 20 e 37 KDa de P. falciparum. Por outro lado, os experimentos in vivo não mostraram eficácia do tratamento do POH contra PbGFP em camundongos Balb/c. Em contraste, foi demostrada a eficácia do POH na de malária cerebral experimental (MCE), , indicando uma redução na taxa de incidência da MCE no grupo tratado com POH, comparado o não tratado ( P<0,05). Além disso, o POH reduziu a inflamação no cérebro dos animais tratados, uma vez que teve uma redução significativa na adesão de leucócitos aos vasos cerebrais (P<0.001), como também, o numero de hemorragias foi menor comparados com os animais não tratados. (P<0.0001). Portanto, os resultados obtidos nesta pesquisa abrem novas alternativas no estudo do mecanismo de ação do POH como um terpeno com grande potencial para tratar MC. / Malaria kills over one million people a year worldwide, and is one of the most important infectious diseases and a major public health problem. Furthermore, the emergence of resistant strains to chemotherapeutic agents used, make it necessary to study new targets for treatments against this disease. In our laboratory we have demonstrated the isoprenoids biosynthesis in P. falciparum, by the MEP pathway. It is known that the substances that inhibit isoprenoid biosynthesis, among these terpenes, have antimalarial activity in vitro and in vivo. Considering this, we evaluate the antimalarial potential of PA (POH) in P. falciparum and P. berghei. Our results showed that the POH had inhibitory effect against the growth of strains 3D7 and K1 of P. falciparum in vitro, with an IC50 of 4.8 &mu;M ± 0.5, and 10.41 ± 2.33 &mu;M, respectively. Furthermore, the POH had no toxic effect on cell line Vero. Moreover, the POH proved that inhibited proteins farnesylation from 20 to 37 kDa of P.falciparum. On the other hand, in vivo experiments did not show efficacy on treatment against POH PbGFP in BALB/c mice. In contrast, the effectiveness of POH in the experimental cerebral malaria (MCE) was demonstrated, indicating a reduction in the incidence rate of MCE in the group treated with POH, compared with of untreated animals (P <0.05). In addition, the POH reduced inflammation in the brain of treated animals, since it had a significant reduction in leukocyte adhesion to cerebral vessels (P <0.001), as also the number of bleeding was lower compared to untreated animals (P<0.0001). Therefore, the results obtained in this work provide new alternatives to study the POH\'s mechanism of action as a terpene with great potential to treat MC.